0.54
-0.0157(-2.81%)
Currency In USD
| Previous Close | 0.56 |
| Open | 0.55 |
| Day High | 0.56 |
| Day Low | 0.54 |
| 52-Week High | 3.29 |
| 52-Week Low | 0.34 |
| Volume | 457,610 |
| Average Volume | 865,857 |
| Market Cap | 46.78M |
| PE | -2.01 |
| EPS | -0.27 |
| Moving Average 50 Days | 0.56 |
| Moving Average 200 Days | 0.94 |
| Change | -0.02 |
If you invested $1000 in Century Therapeutics, Inc. (IPSC) since IPO date, it would be worth $23.78 as of July 01, 2025 at a share price of $0.543. Whereas If you bought $1000 worth of Century Therapeutics, Inc. (IPSC) shares 3 years ago, it would be worth $61.77 as of July 01, 2025 at a share price of $0.543.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress
GlobeNewswire Inc.
May 28, 2025 8:01 PM GMT
PHILADELPHIA, May 28, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today
Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
GlobeNewswire Inc.
Apr 28, 2025 8:30 PM GMT
PHILADELPHIA, April 28, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, toda
Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025
GlobeNewswire Inc.
Apr 15, 2025 8:01 PM GMT
PHILADELPHIA, April 15, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, toda